SpineGuard SA announced a private placement of 500,000 common shares at an issue price of â¬1 per share for the gross proceeds of â¬500,000 on May 16, 2023. The transaction included participation from new investor SuZhou Xinrong Best Medical Instrument Co., Ltd representing 1.28% stake of current issued shares. The shares are restricted to a hold period of 18 months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2285 EUR | -2.77% | +3.39% | +14.48% |
04-17 | SpineGuard SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | SpineGuard SA announced that it expects to receive ?1.998 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+14.48% | 11.69M | |
+73.43% | 12.41B | |
-16.51% | 8.14B | |
+16.03% | 7.2B | |
+4.95% | 5.93B | |
+13.07% | 5.43B | |
+36.46% | 4.89B | |
-19.82% | 4.09B | |
-34.06% | 2.49B | |
+1.73% | 2.04B |
- Stock Market
- Equities
- ALSGD Stock
- News SpineGuard
- SpineGuard SA announced that it has received €0.5 million in funding from SuZhou Xinrong Best Medical Instrument Co., Ltd